Cassava Sciences, Inc.
SAVA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $106 | $112 | $117 | $129 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1 | $1 | $1 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $2 | $2 | $7 |
| Total Curr. Assets | $109 | $115 | $120 | $137 |
| Property Plant & Equip (Net) | $21 | $21 | $21 | $21 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $21 | $21 | $21 | $21 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $130 | $135 | $141 | $158 |
| Liabilities | – | – | – | – |
| Payables | $46 | $43 | $8 | $8 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2 | $5 | $5 | $4 |
| Total Curr. Liab. | $48 | $47 | $13 | $12 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $48 | $47 | $13 | $12 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$484 | -$473 | -$429 | -$405 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $565 | $561 | $556 | $551 |
| Total Equity | $82 | $88 | $128 | $146 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $130 | $135 | $141 | $158 |
| Net Debt | -$106 | -$112 | -$117 | -$129 |